Tag Archives: benefit coverage

Biopharma, employer, Rare/Orphan Disease

Employer Plans View Product Coverage Very Differently from PBMs

Posted on by John Santilli

Employers’ benefit coverage decisions and the impact those decisions have on the market for rare disease / orphan drugs are a growing concern for biopharma companies

Continue reading →
Biopharma, Commercialization, employer

Did You Know Market Access is Closing Down

Posted on by John Santilli

Biopharma companies need to see the employer market clearly in the short and long-term to be able to understand payers management methods for orphan drugs and the impact those decisions will have on their drugs

Continue reading →
Specialty Drug

Buy and Bill Trend: Are there Contradictions to Vendor or Pharma’s Reported Data

Posted on by John Santilli

Buy and Bill Trend:  Are there Contradictions to Vendor or Pharma’s Reported Data Distribution based sales of specialty pharmaceuticals raises critical issues for manufacturers and providers as plan year 2016 decisions have been made and 2017 preparations begin by purchasers. For pharmaceutical manufacturers, the dilemma arises when (1) reimbursement is limited or eliminated under benefit […]

Continue reading →